Immunization with the Malaria Diversity-Covering Blood-Stage Vaccine Candidate Plasmodium falciparum Apical Membrane Antigen 1 DiCo in Complex with Its Natural Ligand PfRon2 Does Not Improve the In Vitro Efficacy
The blood-stage malaria vaccine candidate Plasmodium falciparum apical membrane antigen 1 (PfAMA1) can induce strong parasite growth-inhibitory antibody responses in animals but has not achieved the anticipated efficacy in clinical trials. Possible explanations in humans are the insufficient potency...
Main Authors: | Holger Spiegel, Alexander Boes, Rolf Fendel, Andreas Reimann, Stefan Schillberg, Rainer Fischer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fimmu.2017.00743/full |
Similar Items
-
Plant-based production of recombinant Plasmodium surface protein pf38 and evaluation of its potential as a vaccine candidate.
by: Tatjana Feller, et al.
Published: (2013-01-01) -
Isolation and light chain shuffling of a Plasmodium falciparum AMA1-specific human monoclonal antibody with growth inhibitory activity
by: Melanie Seidel-Greven, et al.
Published: (2021-01-01) -
Establishment of an Agrobacterium-mediated Inoculation System for Cucumber Green Mottle Mosaic Virus
by: Minji Kang, et al.
Published: (2015-12-01) -
Application of a scalable plant transient gene expression platform for malaria vaccine development
by: Holger eSpiegel, et al.
Published: (2015-12-01) -
Protective oral vaccination against infectious bursal disease virus using the major viral antigenic protein VP2 produced in Pichia pastoris.
by: Omid Taghavian, et al.
Published: (2013-01-01)